Persisting posttransplantation cytomegalovirus antigenemia correlates with poor lymphocyte proliferation to cytomegalovirus antigen and predicts for increased late relapse and treatment failure

Biology of Blood and Marrow Transplantation

Volumn 10, Issue 1, 2004, Pages 49-57

  Nakamura, Ryotaro ^a   Battiwalla, Minoo ^a   Solomon, Scott ^a   Follmann, Dean ^a   Chakrabarti, Sakti ^a   Cortez, Karoll ^b   Hensel, Nancy ^a   Childs, Richard ^a   Barrett, A John ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Allogeneic stem cell transplantation; CMV antigenemia; Cytomegalovirus; Immune reconstitution

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; BUSULFAN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTOMEGALOVIRUS ANTIGEN PP65; FLUCONAZOLE; GANCICLOVIR; GRANULOCYTE COLONY STIMULATING FACTOR; VIRUS ANTIGEN;

ADULT; ARTICLE; CANCER INCIDENCE; CANCER RECURRENCE; CANCER SURVIVAL; CHRONIC MYELOID LEUKEMIA; CLINICAL STUDY; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DONOR; FEMALE; FOLLOW UP; GRAFT VERSUS LEUKEMIA EFFECT; HLA MATCHING; HUMAN; IMMUNE DEFICIENCY; IMMUNOCOMPETENCE; LYMPHOCYTE COUNT; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTIVARIATE ANALYSIS; PREDICTION; RECIPIENT; RELAPSE; SIBLING; SIDE EFFECT; STEM CELL TRANSPLANTATION; T LYMPHOCYTE; TREATMENT FAILURE; VIRUS REACTIVATION;

ADOLESCENT; ADULT; ANTIGENS, VIRAL; CHILD; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; LYMPHOCYTE DEPLETION; MALE; MIDDLE AGED; RECURRENCE; TRANSPLANTATION, HOMOLOGOUS; TREATMENT FAILURE; VIRUS ACTIVATION;

EID: 0742323848     PISSN: 10838791     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbmt.2003.08.011     Document Type: Article

References (32)

1. Meyers J.D. Flournoy N. Thomas E.D. Risk factors for cytomegalovirus infection after human marrow transplantation J Infect Dis. 153 1986 478-488
2. Enright H. Haake R. Weisdorf D. et al. Cytomegalovirus pneumonia after bone marrow transplantation. Risk factors and response to therapy Transplantation. 55 1993 1339-1346
3. Reed E.C. Bowden R.A. Dandliker P.S. Lilleby K.E. Meyers J.D. Treatment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants Ann Intern Med. 109 1988 783-788
4. Nakamura R. Cortez K. Solomon S. et al. High-dose acyclovir and pre-emptive ganciclovir to prevent cytomegalovirus disease in myeloablative and non-myeloablative allogeneic stem cell transplantation Bone Marrow Transplant. 30 2002 235-242
5. Reusser P. Riddell S.R. Meyers J.D. Greenberg P.D. Cytotoxic T-lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease Blood 78 1991 1373-1380
6. Reusser P. Attenhofer R. Hebart H. Helg C. Chapuis B. Einsele H. Cytomegalovirus-specific T-cell immunity in recipients of autologous peripheral blood stem cell or bone marrow transplants Blood. 89 1997 3873-3879
7. Quinnan G.V. Jr. Burns W.H. Kirmani N. et al. HLA-restricted cytotoxic T lymphocytes are an early immune response and important defense mechanism in cytomegalovirus infections Rev Infect Dis. 6 1984 156-163
8. Li C.R. Greenberg P.D. Gilbert M.J. Goodrich J.M. Riddell S.R. Recovery of HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant: correlation with CMV disease and effect of ganciclovir prophylaxis Blood 83 1994 1971-1979
9. Krause H. Hebart H. Jahn G. Muller C.A. Einsele H. Screening for CMV-specific T cell proliferation to identify patients at risk of developing late onset CMV disease Bone Marrow Transplant. 19 1997 1111-1116
10. Hebart H. Daginik S. Stevanovic S. et al. Sensitive detection of human cytomegalovirus peptide-specific cytotoxic T-lymphocyte responses by interferon-gamma-enzyme-linked immunospot assay and flow cytometry in healthy individuals and in patients after allogeneic stem cell transplantation Blood 99 2002 3830-3837
11. Gratama J.W. van Esser J.W. Lamers C.H. et al. Tetramer-based quantification of cytomegalovirus (CMV)-specific CD8+ T lymphocytes in T-cell-depleted stem cell grafts and after transplantation may identify patients at risk for progressive CMV infection Blood 98 2001 1358-1364
12. Cwynarski K. Ainsworth J. Cobbold M. et al. Direct visualization of cytomegalovirus-specific T-cell reconstitution after allogeneic stem cell transplantation Blood 97 2001 1232-1240
13. Bahceci E. Read E.J. Leitman S. et al. CD34+ cell dose predicts relapse and survival after T-cell-depleted HLA-identical haematopoietic stem cell transplantation (HSCT) for haematological malignancies Br J Haematol. 108 2000 408-414
14. Mavroudis D.A. Read E.J. Molldrem J. et al. T cell-depleted granulocyte colony-stimulating factor (G-CSF) modified allogenic bone marrow transplantation for hematological malignancy improves graft CD34+ cell content but is associated with delayed pancytopenia Bone Marrow Transplant. 21 1998 431-440
15. Nakamura R. Bahceci E. Read E.J. et al. Transplant dose of CD34(+) and CD3(+) cells predicts outcome in patients with haematological malignancies undergoing T cell-depleted peripheral blood stem cell transplants with delayed donor lymphocyte add-back Br J Haematol. 115 2001 95-104
16. Solomon S.R. Nakamura R. Read E.J. et al.Cyclosporine is required to prevent severe acute GVHD following T-cell-depleted peripheral blood stem cell transplantation Bone Marrow Transplant. 31 2003 783-788
17. Barrett A.J. Mavroudis D. Tisdale J. et al. T cell-depleted bone marrow transplantation and delayed T cell add-back to control acute GVHD and conserve a graft-versus-leukemia effect Bone Marrow Transplant. 21 1998 543-551
18. Thomas E. Storb R. Clift R.A. et al. Bone-marrow transplantation (first of two parts) N Engl J Med. 292 1975 832-843
19. Prentice H.G. Gluckman E. Powles R.L. et al. Impact of long-term acyclovir on cytomegalovirus infection and survival after allogeneic bone marrow transplantation. European Acyclovir for CMV Prophylaxis Study Group Lancet 343 1994 749-753
20. Couriel D. Canosa J. Engler H. Collins A. Dunbar C. Barrett A.J. Early reactivation of cytomegalovirus and high risk of interstitial pneumonitis following T-depleted BMT for adults with hematological malignancies Bone Marrow Transplant. 18 1996 347-353
21. Ljungman P. Griffith P. Definition of cytomegalovirus infection and disease In: Michelson S. Plotkin S.A. (Eds.), Multidisciplinary Approach to Understanding Cytomegalovirus Disease 1993 233 Excerpta MedicaAmsterdam
22. Kaplan E. Meier P. Nonparametric estimation from incomplete observations J Am Stat Assoc. 53 1958 457-481
23. Cox D. Regression models and life tables (with discussion) J R Stat Soc B. 34 1972 187-202
24. Mackall C.L. Fleisher T.A. Brown M.R. et al. Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy N Engl J Med. 332 1995 143-149
25. Roux E. Dumont-Girard F. Starobinski M. et al. Recovery of immune reactivity after T-cell-depleted bone marrow transplantation depends on thymic activity Blood 96 2000 2299-2303
26. Douek D.C. Vescio R.A. Betts M.R. et al. Assessment of thymic output in adults after haematopoietic stem-cell transplantation and prediction of T-cell reconstitution Lancet 355 2000 1875-1881
27. Mackall C.L. Bare C.V. Granger L.A. Sharrow S.O. Titus J.A. Gress R.E. Thymic-independent T cell regeneration occurs via antigen-driven expansion of peripheral T cells resulting in a repertoire that is limited in diversity and prone to skewing J Immunol. 156 1996 4609-4616
28. Hazenberg M.D. Otto S.A. de Pauw E.S. et al. T-cell receptor excision circle and T-cell dynamics after allogeneic stem cell transplantation are related to clinical events Blood 99 2002 3449-3453
29. Boeckh M. Leisenring W. Riddell S.R. et al. Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity Blood 101 2003 407-414
30. Bowden R.A. Digel J. Reed E.C. Meyers J.D. Immunosuppressive effects of ganciclovir on in vitro lymphocyte responses J Infect Dis. 156 1987 899-903
31. Naniche D. Oldstone M.B. Generalized immunosuppression: how viruses undermine the immune response Cell Mol Life Sci. 57 2000 1399-1407
32. Powles R. Singhal S. Treleaven J. Kulkarni S. Horton C. Mehta J. Identification of patients who may benefit from prophylactic immunotherapy after bone marrow transplantation for acute myeloid leukemia on the basis of lymphocyte recovery early after transplantation Blood 91 1998 3481-3486